This is the second volume of the Patent eBook Series titled Topics in Anti-Cancer Research. The eBook includes updated chapters on topics relevant to contemporary cancer research published in the journalRecent Patents on Anti-Cancer Drug Discovery.
This volume covers scientific and patented novel chemotherapeutic agents and drugs for metastatic castration-resistant prostate cancer and Ras/ Raf /MEK/ERK pathwayP1KAKT and mTORC1/2 inhibitorsATPase inhibitors for cancer therapyand sphingomyelin biosynthesis which regulates cancer cell death and growth.
Other chapters also explain research on biochemical regulation i.e. cell cycle and energy metabolismthe role of genetic variations of Fc γRs gamma receptors in monoclonal antibody based anti-cancer therapy and effectiveness of antiangiogenic therapyendogenous angiogenesis inhibitors and anti-angiogenic drugs for the treatment of renal cell carcinomaprevention of cancer by ribonucleotide reductaseanticancer activity of Erlotinib in glioblastoma and the mechanisms of action of nanodrugs and nano-sized camptothecin drugs in cancer chemotherapy. The volume also covers recent studies in the field of onconutrition. The broad range of topics covered in this second volume will be of immense interest to cliniciansscientists and R&D experts seeking new targets for the prevention of cancernovel oncogenic biomarkersand methods for cancer therapy.